-
1
BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies
Published 2025-01-01Subjects: “…Bcl-2 inhibitors…”
Get full text
Article -
2
Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML
Published 2025-01-01Subjects: Get full text
Article -
3